Indefinite Delivery Contract SPE2DR25D9368

The federal contract IDV award SPE2DR25D9368 is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 and awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract was awarded by the Defense Logistics Agency (DLA) under the SPE2DB program and covers a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

The original contract opportunity, described as the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), aims to establish multiple regional prime vendor contracts to provide worldwide pharmaceutical support to the Defense Health Agency (DHA), Department of Defense (DoD) customers, the United States Coast Guard, and other government agencies. The contract has a 30-month base period with three 30-month option periods, for a total estimated value of $30.3 billion. Awards will be made on a regional basis, with at least three different contractors selected across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items. The procurement is unrestricted and will use a Lowest Price Technically Acceptable (LPTA) evaluation methodology.